Nintedanib Alleviates Experimental Colitis by Inhibiting CEBPB/PCK1 and CEBPB/EFNA1 Pathways

The super-enhancer, a cluster of enhancers with strong transcriptional activity, has become one of the most interesting topics in recent years. This study aimed to investigate pathogenic super-enhancer–driven genes in IBD and screen therapeutic drugs based on the results. In this study, through the...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hailong, Li, Jinhe, Xiao, Ting, Hu, Yayue, Yang, Ying, Gu, Xiaoting, Jin, Ge, Cao, Hailong, Zhou, Honggang, Yang, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331303/
https://www.ncbi.nlm.nih.gov/pubmed/35910380
http://dx.doi.org/10.3389/fphar.2022.904420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331303/
https://www.ncbi.nlm.nih.gov/pubmed/35910380
http://dx.doi.org/10.3389/fphar.2022.904420

Ejemplares similares